Search results
Showing results for
Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, has raised $2M in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.
Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, has raised $2M in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.